Beruflich Dokumente
Kultur Dokumente
P–04–0519 11/30/04 11/24/04 (G) Substituted benzenesulfonic acid substituted pyrazol azo phenyl amino
triazin amino substituted phenyl compound
P–04–0611 12/07/04 11/03/04 (S) (1r,4s)-4-methoxy-2,2,7,7-tetramethyltricyclo[6.2.1.01,6]undec-5-ene
P–04–0626 12/08/04 11/09/04 (G) Substituted phenol, polymer with polyalkylene polyether polyol and
epichlorohydrin
P–04–0659 12/14/04 11/16/04 (G) N-sulfoalkyl-aminocarbonylalkenyl, polymer modified with n,n-dialkyl-
aminocarbonylalkenyl, calcium salt
P–04–0683 12/06/04 11/23/04 (G) Substituted pyridinecarbonitrile pigment
P–04–0710 12/06/04 11/15/04 (G) Alkyl methacrylate copolymer
P–04–0752 11/30/04 11/12/04 (G) Organomodified siloxane and silicone
P–04–0793 12/06/04 11/20/04 (G) Essential oil
P–04–0815 12/06/04 11/16/04 (G) Styrene acrylic copolymer
P–04–0891 12/01/04 11/02/04 (G) Dynacoll 7250, dynacoll 7140
P–93–1704 12/13/04 11/29/04 (G) Polyester polyol isocyanate polymer reaction products
VerDate jul<14>2003 15:43 Jan 27, 2005 Jkt 205001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\28JAN1.SGM 28JAN1
Federal Register / Vol. 70, No. 18 / Friday, January 28, 2005 / Notices 4127
on respondents, including through the importation and quarantine process for shipments (normally no more than 2),
use of automated collection techniques the arriving nonhuman primates. that the provisions of a special permit
or other forms of information Under the special permit plan are being followed by a new permit
technology. Written comments should arrangement, registered importers must holder and that the use of adequate
be received within 60 days of this submit a plan to CDC for the disease control practices is being
notice. importation and quarantine if they wish demonstrated, the special permit is
to import the specific monkeys covered. extended to cover the receipt of
Proposed Project The plan must address disease additional shipments under the same
prevention procedures to be carried out plan for a period of 180 days, and may
Requirement for a Special Permit to
in every step of the chain of custody of be renewed upon request. This
Import Cynomolgus, African Green, or
such monkeys, from embarkation in the eliminates the burden on importers to
Rhesus Monkeys into the United States country of origin to release from
(0920–0263)—Revision—National repeatedly report identical information,
quarantine. Information such as species, requiring only that specific shipment
Center for Infectious Diseases (NCID), origin and intended use for monkeys,
Centers for Disease Control and itineraries and information on changes
transit information, isolation and
Prevention (CDC). to the plan which require approval be
quarantine procedures, and procedures
A registered importer must request a submitted.
for testing of quarantined animals is
special permit to import Cynomolgus, necessary for CDC to make public health Respondents are commercial or not-
African Green, or Rhesus Monkeys. To decisions. This information enables for-profit importers of nonhuman
receive a special permit to import CDC to evaluate compliance with the primates. The burden represents full
nonhuman primates the importer must standards and to determine whether the submission of information and
submit to the Director of CDC, a written measures being taken to prevent itinerary/change information
plan which specifies the steps that will exposure of persons and animals during respectively. There are no costs to
be taken to prevent exposure of persons importation are adequate. Once CDC is respondents except for their time to
and animals during the entire assured, through the monitoring of complete the requisition process.
Number of Average
Number of responses burden per Total burden
Respondents respondents per response hours
respondent (in hours)
Dated: January 21, 2005. Interested persons are invited to send provided to Medicare beneficiaries. The
Betsey Dunaway, comments regarding this burden Clinical Data Abstraction Centers
Acting Reports Clearance Officer, Office of estimate or any other aspect of this (CDACs) obtain copies of medical
the Chief Science Officer, Centers for Disease collection of information, including any records from which they abstract data to
Control and Prevention. of the following subjects: (1) The analyze patterns of care and outcomes
[FR Doc. 05–1589 Filed 1–27–05; 8:45 am] necessity and utility of the proposed for heart failure/myocardial infarction,
BILLING CODE 4163–18–P information collection for the proper pneumonia, diabetes and surgical
performance of the agency’s function; infection; Frequency: When records are
(2) the accuracy of the estimated reviewed; Affected Public: Business or
DEPARTMENT OF HEALTH AND burden; (3) ways to enhance the quality, other for-profit, Not-for-profit
HUMAN SERVICES utility, and clarity of the information to institutions, Federal Government, and
be collected; and (4) the use of State, Local or Tribal Government;
Centers for Medicare & Medicaid automated collection techniques or Number of Respondents: 6,100; Total
Services other forms of information technology to Annual Responses: 397,500; Total
minimize the information collection Annual Hours: 11,925.
[Document Identifier: CMS–R–50 and CMS– 2. Type of Information Collection
burden.
10054]
1. Type of Information Collection Request: Extension of a currently
Agency Information Collection Request: Extension of a currently approved collection; Title of
Activities: Submission for OMB approved collection; Title of Information Collection: Recognition of
Review; Comment Request Information Collection: Medical Records Payment for New Technology Services
Review under Inpatient PPS and for Ambulatory Payment Classifications
AGENCY: Centers for Medicare & Supporting Regulations in 42 CFR, (APCs) Under the Outpatient
Medicaid Services, HHS. Sections 412.40–412.52; Form No: Prospective Payment System and
In compliance with the requirement CMS–R–50 (OMB# 0938–0359); Use: Supporting Regulations in 42 CFR,
of section 3506(c)(2)(A) of the The Quality Improvement Organizations Sections 413.65 and 419.42; Form
Paperwork Reduction Act of 1995, the (QIOs) are authorized to conduct Number: CMS–10054 (OMB# 0938–
Centers for Medicare & Medicaid medical review activities under the 0860); Use: Information is necessary to
Services (CMS), Department of Health Prospective Payment System (PPS). In determine eligibility of medical devices
and Human Services, is publishing the order to conduct these review activities, for establishment of additional device
following summary of proposed CMS depends upon hospitals to make categories for payment under
collections for public comment. available specific records regarding care transitional pass-through payment
VerDate jul<14>2003 15:43 Jan 27, 2005 Jkt 205001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\28JAN1.SGM 28JAN1